| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-07 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.22 | 0.005 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.04 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.02 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.006 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.28 | 0.009 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.001 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.0005 |